Business Segment, Product and Geographic Information

The Company’s business operates in one segment based upon the Company’s organizational structure, the way in which the operations are managed and evaluated by the chief operating decision maker and the lack of availability of discrete financial information.

The company operates under three products lines for revenues; Spine Surgery Products, Biologics and a Monitoring Service. The Company’s Spine Surgery Product line offerings, which include thoracolumbar product offerings, cervical offerings, and a set of motion preservation products still under development, are primarily used to enable access to the spine and to perform restorative and fusion procedures in a minimally disruptive fashion. The Company’s Biologic product line offerings includes allograft (donated human tissue), FormaGraft^®, a collagen synthetic product, Osteocel Plus^®, an allograft cellular matrix containing viable mesenchymal stem cells, or MSCs, and AttraX^®, a synthetic bone graft material, all used to aid the spinal fusion process. The Company’s Monitoring Service offering includes IOM services. Revenue by product line offerings was as follows (in thousands):



	Three Months Ended March 31,
	2014		2013
Spine Surgery Products	$	137,308	$	122,667
Biologics	29,489		27,156
Monitoring Service	10,699		9,681
Total Revenue	$	177,496	$	159,504

Revenue and property and equipment, net, by geographic area were as follows (in thousands):



	Revenue				Property and Equipment, Net
	Three Months Ended March 31,				March 31,		December 31,
	2014		2013		2014		2013
United States	$	158,394	$	146,222	$	108,924	$	109,458
International (excludes Puerto Rico)	19,102		13,282		19,933		18,606
Total	$	177,496	$	159,504	$	128,857	$	128,064